29 April 2021
Avingtrans Plc
("Avingtrans" or the "Company" or the "Group")
Director Shareholdings, Exercise of EBT Options and Total Voting Rights
Avingtrans plc, which designs, manufactures and supplies critical components, modules and associated services to the energy and medical sectors, announces certain dealings in its shares.
Shares Awarded Under Joint Ownership EBT
116,330 ordinary shares are to be awarded to certain PDMRs of the Company out of the Company's Employee Benefit Trust (the "EBT Shares"). The details of these awards, together with the resultant shareholdings, are set out below.
Name |
Role |
Current shareholding |
Number of shares awarded |
Resultant shareholding |
Resultant percentage holding |
Steve McQuillan |
Chief Executive Officer |
351,601 |
65,148 |
416,749(1) |
1.30% |
Stephen King |
Chief Financial Officer |
310,253 |
51,182 |
361,435(2) |
1.13% |
(1) This figure includes 335,582 held by Sheena McQuillan
(2) This figure includes 310,253 held by Helen King
Total Voting Rights
There's is no change due to the above, the Company will have a total of 31,971,307 ordinary shares in issue. The Company does not hold any shares in Treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.
Avingtrans plc |
01354692391 |
Roger McDowell, Chairman Steve McQuillan, Chief Executive Officer Stephen King,ChiefFinancialOfficer |
|
N+1 Singer(NominatedAdviser) |
02074963000 |
Shaun Dobson/Alex Bond(CorporateFinance)RachelHayes(CorporateBroking) |
|
SEC Newgate (Financial PR) |
02076539850 |
Adam Lloyd/ Tom Carnegie |
About Avingtrans plc:
Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.
Specialises in the design, manufacture and servicing of performance-critical motorsand pumps for challenging environments.
Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions;
product refurbishment; on-site technical support.
Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising
in precision pressure and vacuum vessels and associated fabrications, sub- assemblies and systems.
Designs, manufactures, installs and services doors and walls which can be tailoredto be: blast
&explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above
Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products
Centre for composite technology, parts and assemblies, serving customers in industrial markets.
Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for
Nuclear Magnetic Resonance instruments.
Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and
Nuclear Magnetic Resonance (NMR) systems.
Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has remained at the forefront of MRI systems technology,
successfully designing and commercialising a 1.5 Tesla extremity MRI superconducting magnet that is now the heart ofover two hundred MRI systems world-wide. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going.
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|||||||
a)
|
Name
|
Steve McQuillan |
||||||
2
|
Reason for the notification
|
|||||||
a)
|
Position/status
|
PDMR |
||||||
|
Initial notification /Amendment
|
Initial notification |
||||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a)
|
Name
|
Avingtrans PLC |
||||||
b)
|
LEI
|
213800ZZ96CKPI423E86
|
||||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares of 5p each |
||||||
|
|
|||||||
Identification code |
ISIN: GB0009188797
|
|||||||
|
|
|||||||
b)
|
Nature of the transaction
|
Award of Shares
|
||||||
c)
|
Price(s) and volume(s) |
|
|
|
|
|||
|
|
|
|
|
||||
d)
|
Aggregated information |
n/a |
||||||
|
|
|||||||
- Aggregated volume |
|
|||||||
|
|
|||||||
- Price |
|
|||||||
|
|
|||||||
e)
|
Date of the transaction
|
29 April 2021 |
||||||
f)
|
Place of the transaction
|
Off market |
1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|||||||
a)
|
Name
|
Stephen King |
||||||
2
|
Reason for the notification
|
|||||||
a)
|
Position/status
|
PDMR |
||||||
|
Initial notification /Amendment
|
Initial notification |
||||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a)
|
Name
|
Avingtrans PLC |
||||||
b)
|
LEI
|
213800ZZ96CKPI423E86
|
||||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares of 5p each |
||||||
|
|
|||||||
Identification code |
ISIN: GB0009188797
|
|||||||
|
|
|||||||
b)
|
Nature of the transaction
|
Award of Shares
|
||||||
c)
|
Price(s) and volume(s) |
|
|
|
|
|||
|
|
|
|
|
||||
d)
|
Aggregated information |
n/a |
||||||
|
|
|||||||
- Aggregated volume |
|
|||||||
|
|
|||||||
- Price |
|
|||||||
|
|
|||||||
e)
|
Date of the transaction
|
29 April 2021 |
||||||
f)
|
Place of the transaction
|
Off market |